ATE462443T1 - Dehnungsstreifenbehandlung mit botulinumtoxin - Google Patents

Dehnungsstreifenbehandlung mit botulinumtoxin

Info

Publication number
ATE462443T1
ATE462443T1 AT05791811T AT05791811T ATE462443T1 AT E462443 T1 ATE462443 T1 AT E462443T1 AT 05791811 T AT05791811 T AT 05791811T AT 05791811 T AT05791811 T AT 05791811T AT E462443 T1 ATE462443 T1 AT E462443T1
Authority
AT
Austria
Prior art keywords
botulinum toxin
stretch marks
treatment
marks treatment
stretch
Prior art date
Application number
AT05791811T
Other languages
English (en)
Inventor
Eric First
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE462443T1 publication Critical patent/ATE462443T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05791811T 2004-09-03 2005-08-24 Dehnungsstreifenbehandlung mit botulinumtoxin ATE462443T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/934,812 US7429386B2 (en) 2004-09-03 2004-09-03 Stretch mark treatment
PCT/US2005/030285 WO2006028724A1 (en) 2004-09-03 2005-08-24 Stretch mark treatment with botulinum toxic

Publications (1)

Publication Number Publication Date
ATE462443T1 true ATE462443T1 (de) 2010-04-15

Family

ID=35447629

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05791811T ATE462443T1 (de) 2004-09-03 2005-08-24 Dehnungsstreifenbehandlung mit botulinumtoxin

Country Status (10)

Country Link
US (1) US7429386B2 (de)
EP (1) EP1784205B1 (de)
KR (1) KR101211890B1 (de)
AT (1) ATE462443T1 (de)
AU (1) AU2005282967A1 (de)
CA (1) CA2581934C (de)
DE (1) DE602005020309D1 (de)
DK (1) DK1784205T3 (de)
ES (1) ES2340782T3 (de)
WO (1) WO2006028724A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7824693B2 (en) 2002-08-19 2010-11-02 Ira Sanders Treatment of fine wrinkles with clostridia neurotoxins
US20120114697A1 (en) 2002-08-19 2012-05-10 Ira Sanders Treatment of holocrine gland dysfunction with clostridia neurotoxins
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
US9044477B2 (en) * 2007-12-12 2015-06-02 Allergan, Inc. Botulinum toxin formulation
US9308070B2 (en) 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
US20110008406A1 (en) * 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
FR2973246B1 (fr) 2011-03-31 2013-04-12 Nuxe Lab Composition a base de camellia japonica pour la protection de la peau.
FR2977797B1 (fr) 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
WO2015126527A1 (en) * 2014-02-18 2015-08-27 Kaufman-Janette Joely Botulinum neurotoxin for use in the prophylactic treatment of cutaneous wounds
HUE055368T2 (hu) * 2016-08-12 2021-11-29 Biomup France Sas Vérzéscsillapító folyadék
CA3057302A1 (en) * 2017-03-22 2018-09-27 Bonti, Inc. Botulinum neurotoxins for use in therapy
US11191819B2 (en) 2018-08-28 2021-12-07 Ira Sanders Skin therapeutics

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US613915A (en) * 1898-11-08 Manufacture of non-intoxicating beverages
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US5670484A (en) * 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
ES2238969T3 (es) * 1994-05-09 2005-09-16 William J. Binder Neurotoxinas presinapticas para el tratamiento de cefaleas migrañosas.
GB9508204D0 (en) * 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
DE69833059T3 (de) * 1997-07-15 2014-12-18 The Regents Of The University Of Colorado, A Body Corporate Verwendung von Botulinumtoxin zur Behandlung von Harninkontinenz
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
US6660301B1 (en) 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
EP0947433A1 (de) * 1998-04-03 1999-10-06 Tetra Laval Holdings & Finance SA Öffnungseinrichtung für Behälter mit fleissfähigem Lebensmittel
GB9818548D0 (en) 1998-08-25 1998-10-21 Microbiological Res Authority Treatment of mucas hypersecretion
TW574036B (en) 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin
KR20010089347A (ko) * 1998-10-27 2001-10-06 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 상처 치료 증진 방법
DE19852981A1 (de) 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
GB9907429D0 (en) 1999-03-31 1999-05-26 Microbiological Res Authority Modulation of C-fibre activity
DE19925739A1 (de) 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
US6358917B1 (en) * 1999-08-24 2002-03-19 Jean D. A. Carruthers Cosmetic use of botulinum toxin for treatment of downturned mouth
GB9922554D0 (en) 1999-09-23 1999-11-24 Microbiological Res Authority Inhibition of secretion from non-neuronal cells
US6113915A (en) 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6265379B1 (en) * 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) * 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6143306A (en) * 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6261572B1 (en) * 2000-01-11 2001-07-17 Allergan Sales, Inc. Method for treating a pancreatic disorder with a neurotoxin
US6753315B2 (en) * 2000-02-24 2004-06-22 Brown University Research Foundation α-bungarotoxin molecules and uses thereof
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) * 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US6787517B1 (en) * 2000-12-29 2004-09-07 Allergan, Inc. Agent and methods for treating pain
PT1411978E (pt) 2001-07-27 2008-11-28 Univ Louisiana State Toxina botulínica no tratamento ou prevenção do acne
US6623742B2 (en) * 2001-09-17 2003-09-23 Allergan, Inc. Methods for treating fibromyalgia
EP1487481A4 (de) * 2002-03-01 2005-11-23 Elan Pharm Inc Verfahren zur behandlung von nerveneinklemmungssyndromen
CN1383811A (zh) 2002-05-16 2002-12-11 卢伟成 一种除皱化妆品及其制作工艺
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions

Also Published As

Publication number Publication date
US20060051377A1 (en) 2006-03-09
EP1784205A1 (de) 2007-05-16
ES2340782T3 (es) 2010-06-09
AU2005282967A1 (en) 2006-03-16
CA2581934C (en) 2012-11-27
KR20070057908A (ko) 2007-06-07
DK1784205T3 (da) 2010-06-21
EP1784205B1 (de) 2010-03-31
WO2006028724A1 (en) 2006-03-16
US7429386B2 (en) 2008-09-30
CA2581934A1 (en) 2006-03-16
DE602005020309D1 (de) 2010-05-12
KR101211890B1 (ko) 2012-12-14

Similar Documents

Publication Publication Date Title
ATE462443T1 (de) Dehnungsstreifenbehandlung mit botulinumtoxin
DK2282766T3 (da) Suturlinie-indgivelsesteknik med anvendelse af botulinumtoksiner
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
CY1114792T1 (el) Κλωστριδιακες τοξινες για χρηση στην θεραπεια προωρης εκσπερματισης
ATE518882T1 (de) Mit clostridientoxin aktivierbare clostridientoxine
NZ593111A (en) Antibacterial compounds
DK1322324T3 (da) Fremgangsmåder til behandling af muskelskader
TW200618808A (en) Methods for treating diverse cancers
TW200503751A (en) Methods for treating sinus headache
ATE416191T1 (de) Abbaubare clostridientoxine
MX356176B (es) Metodos para usar moduladores de c-met.
NZ601350A (en) Method of treating arthritis
PT1492561E (pt) Metodo para tratar disturbios da glandula mamaria
NO20075119L (no) Nedbrytbare geler for anvendelse i soneisolering
DOP2010000302A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
ATE347898T1 (de) Botulinustoxine zur behandlung von priapismus
UA107562C2 (uk) Спосіб лікування псоріазу
ATE444076T1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
BRPI0514836A (pt) uso de toxina botulìnica para tratamento de uma deformidade da nádega
DK1729796T3 (da) Behandling af tryksår
BRPI0514895A (pt) tratamento de estria
CO2019008575A2 (es) Métodos para tratar infecciones bacterianas
WO2006127642A3 (en) Use of botulinum toxin for treating peritoneal adhesions
MX2010003695A (es) Uso de la secuencia codificante del dominio carboxilo terminal de la cadena pesada de la toxina tetanica como medicamento.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties